✦ LIBER ✦

Future Therapies for the Myeloproliferative Neoplasms

✍ Scribed by Robyn Scherber; Ruben A. Mesa

Book ID: 107540291
Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 127 KB
Volume: 6
Category: Article
ISSN: 1558-8211
DOI: 10.1007/s11899-010-0068-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future therapies for the treatment of bl

Future therapies for the treatment of bladder neoplasms

✍ William A. See; Craig J. Berman 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

The last several decades have witnessed an exponential growth in the understanding of the biology of human neoplasms. As a consequence, a number of new strategies for the treatment of urologic cancers are currently under evaluation. We provide an overview of promising new treatment approaches as the

Interferon-α therapy in bcr-abl-negative

Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms

✍ Kiladjian, J-J; Chomienne, C; Fenaux, P 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Prodromal myeloproliferative neoplasms:

Prodromal myeloproliferative neoplasms: The 2008 WHO classification

✍ Hans Michael Kvasnicka; Juergen Thiele 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

## Abstract The concept of prodromal chronic myeloproliferative neoplasms has been endorsed by the WHO classification implicating a stepwise evolution of disease. Histology of the bone marrow (BM) and borderline to mildly expressed clinical features play a pivotal role for diagnosing prefibrotic‐ea

JAK2Mutation and Thrombosis in the Myelo

JAK2Mutation and Thrombosis in the Myeloproliferative Neoplasms

✍ Alessandro M. Vannucchi 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 144 KB

Future therapies for hepatitis C

✍ Asim S. Khokhar; Valerie Byrnes; Nezam H. Afdhal 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 211 KB

Therapies of the Future

📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB